Goal Directed Therapy : Liberal vs Restrictive Transfusion.. Syafri Kamsul Arif

Similar documents
Blood transfusions in sepsis, the elderly and patients with TBI

Dr Tushar Mahambrey. Consu ltant Critical Care Med icine & Anaesthetics St Helens and Knowsley N H S teaching hospitals Liverpool

Blood Product Utilization A Mythbusters! Style Review. Amanda Haynes, DO 4/28/18

Blood transfusions in ICU: double-edged sword. Paul Hébert, MD MHSc(Epid) Physician-in-Chief, CHUM Professor, University of Montreal

Transfusion Medicine Potpourri. BUMC - Phoenix Internal Medicine Residents September 29, 2015

Blood Management 2016

Transfusion & Mortality. Philippe Van der Linden MD, PhD

Blood Transfusion Project. Reducing Transfusion in the MARCQI Population

Rationale for RBC Transfusion in SCD

Dr Marina Karakantza Consultant Haematologist, NHSBT

2016 Re-Audit of Patient Blood Management in adults undergoing elective, scheduled surgery

EVIDENCE BASED RED CELL TRANSFUSION. Rana Samuel, MD DIRECTOR, PATHOLOGY AND LABORATORY MEDICINE VA WNY Health Care System

Chest diseases Hospital Laboratory Hematology Practice guidelines

Transfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components

Advances in Transfusion and Blood Conservation

Transfusion Limbo How Low Will You Go? Safely. Nina A. Guzzetta, M.D. Children s Healthcare of Atlanta Emory University School of Medicine

Blood is serious business

AN AUDIT OF BLOOD PRODUCTS USAGE in adult cardiac surgery at CMJAH/WITS towards minimal or zero blood usage SM MOGALADI 10/11/2017 SAHA SANDTON

JOURNAL CLUB INDICATIONS FOR AND ADVERSE EFFECTS OF RED CELL TRANSFUSION. Maggie Woods PGY-3

Supplementary Online Content

Red Cell Transfusion triggers: A moving target When, who, and how much?

Transfusion triggers in acute coronary syndromes: The MINT trial

Alternatives to RBC Transfusion: Erythropoietin and beyond

Thinking Twice About Transfusions: When TACOS and TRALIs Turn Treatment Into Tragedy. Megan Boysen Osborn, MD, MHPE

Three decades of transfusion Toronto, Critical Care Canada Forum, October 30, 2014.

Blood Transfusion Guidelines in Clinical Practice

Transfusion for the sickest ICU patients: Are there unanswered questions?

Boot Camp Transfusion Reactions

Preoperative anemia Common, consequential and correctable in non-emergent surgery By Kathrine Frey, MD

Controversies in Transfusion Medicine

HB TRIGGER & SINGLE UNITS

Clinical Impact of Red-Cell Storage Lesion A Survey and Possible Consequences

HMO: Medical (provider setting); Rx (out patient) PPO/CDHP: Rx

Mary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital

Haematology and Transfusion

Where Blood Matters AIMS. National Scientific Meeting. Darwin Convention Centre September Morteza Mohajeri, MD, FRACS ( Cardiothoracic )

Perioperative Goal- Protocol Summary

Perioperative Goal- Protocol Summary

CrackCast Episode 7 Blood and Blood Components

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE

Pre-operative Anaemia Colorectal and Orthopaedic Surgery

Transfusions in Acute Care Too Little?

Transfusion Triggers. Richard Soutar January 2012

Blood Management: Improve Transfusion, Decrease Costs!

Blood Transfusion. Dr William Dooley

Clinical relevance of perioperative ScvO 2 monitoring

Patient Blood Management: Enough is Enough

How we View & Approach TACO

Transfusion Reactions. Directed by M-azad March 2012

RESEARCH. Lars B Holst, 1 Marie W Petersen, 1 Nicolai Haase, 1 Anders Perner, 1 Jørn Wetterslev 2. What is already known on this topic

Transfusion Medicine Update KEMC Nov 5, 2014

Alternatives to RBC Transfusion:

Liberale versus restriktive EK-Transfusion

Blood and blood component therapy in the critically ill patient

Preoperative tests (update)

Crossmatching and Issuing Blood Components; Indications and Effects.

Defining Optimal Perfusion during CPB. Carlo Alberto Tassi Marketing Manager Eurosets Italy

Clinical guideline: manual red cell exchange in patients with sickle cell disease

Components of Blood. N26 Blood Administration 4/24/2012. Cabrillo College ADN/C. Madsen RN, MSN 1. Formed elements Cells. Plasma. What can we give?

Transfusion. National Clinical Guideline Centre. Blood transfusion. Clinical guideline. November Final version.

Downloaded from:

Dr Rock LEUNG Transfusion Safety Officer Queen Mary Hospital, Hong Kong West Cluster

SEPSIS: Seeing Through the. W. Graham Carlos MD, MSCR, ATSF, FACP

Blood Transfusion. Dr Will Dooley

efs.sante.fr The best blood donor and blood product for each patient: an evolving role for haemovigilance? Pierre Tiberghien Etablissement Français du

Pulmonary complications in the Elderly. Paula Bolton-Maggs Medical Director

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

Transfusion Requirements and Management in Trauma RACHEL JACK

Why Old Blood is Bad. tales from the electronic perfusion record. Molly Marko, BS, BSE, CCP Geisinger Health System Danville, Pennsylvania

Edwards Critical Care Education. Perioperative Goal-Directed Therapy Protocol Summary

Edwards Critical Care Education. Perioperative Goal-Directed Therapy Protocol Summary

Edwards Critical Care Education. Perioperative Goal-Directed Therapy Protocol Summary

Blood Conservation : Current concepts in transfusion medicine

Transfusion in Sickle Cell Disease What the guidelines [are likely to] say. Dr Bernard Davis Whittington Hospital, London

Early Goal-Directed Therapy

TRANSFUSION REACTIONS

Blood/Blood Component Utilization and Administration Annual Compliance Education

Heinz-Hermann Weitkemper, EBCP. 4th Joint Scandinavian Conference in Cardiothoracic Surgery 2012 Vilnius / Lithuania

2017 Repeat Audit of Red cell and Platelet Transfusion in Adult Haematology Patients

Clinical Controversies in Perioperative Medicine

Red blood cell transfusions Risks, benefits, and surprises

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?

Austrian Society for Blood Transfusion and Regenerative Medicine. Klagenfurt - May 2015

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion?

The Concept of Patient Blood Management Daniela Filipescu, MD, PhD, DEAA

TRANSFUSION OVERUSE. Exposing an International Problem and Patient Safety Issue

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests

IMPROVE PATIENT OUTCOMES AND SAFETY IN ADULT CARDIAC SURGERY.

Blood Transfusions in Children with Haemoglobinopathies

Patient Blood Management. Marisa B. Marques, MD UAB Department of Pathology November 17, 2016

For more information about how to cite these materials visit

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine

Principles of rational haemotherapy. Complications of blood transfusion

Pre-operative Assessment

WRHA Blood Conservation Service WRHA Transfusion Practice Committee. TEAM TRANSFUSION Differential Diagnosis of Adverse Events

Clinical Controversies in Perioperative Medicine!

Patient Blood Management in the Netherlands: Between practice and evidence

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

BLOOD TRANSFUSION. Dr Lumka Ntabeni

Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease

Transcription:

Goal Directed Therapy : Liberal vs Restrictive Transfusion. Syafri Kamsul Arif

Sepsis Perioperative EGDT PGDT

PGDT Protocol Stroke volume optimization with fluid protocol SVV or PPV based GDT Protocol

Why a protocol? To maintain adequate circulations To ensuring adequate tissue oxygenation To ensure proper waste removal. requires Adequate Adequate Oxygenation Delivery Adequate Content requires

Adequate Delivery DO 2 = CO x CaO 2 DO 2 = CO x (1.39 x Hb x SaO 2 + PaO 2 x 0.003) Fall in Hb reduced arterial oxygen content Fall in DO 2 (Unless compensated)

Risks of RBC Transfusion Early Late Haemolytic reactions immediate or delayed Non-haemolytic febrile reactions Transfusion-associated circulatory overload Transfusion-associated acute lung injury Citrate toxicity Electrolyte disturbances hyperkalaemia Hypothermia Post-transfusion purpura Infection Viral hepatitis A, B, C, E, HIV Bacterial Parasites Graft vs host disease Transfusion-related iron overload Immunomodulation

Allogeneic blood transfusion (ABT) related mortality Acute Lung Injury (TRALI) ABO and non-abo hemolytic transfusion reactions (HTRs) Transfusion-associated sepsis (TAS)

French, 1994-1999 82 transfusion-related deaths 18 deaths due to TAS 6 deaths due to ABO HTRs

SHOTS - UK 1996-2007 115 transfusion related deaths in UK Lowest mortality rate in 2007 0 death definitely attributable to ABT 1 death was probably attributed to TRALI

Liberal Transfusion Strategy Restrictive Transfusion Strategy

RCT of RBC transfusion consistently support the restrictive approach in most settings Degree which the optimal Hb or transfusion trigger should be modified for patients with additional specific risk factors (e.g. ischaemic heart disease) is less clear. It is sensible to modify the decision to transfuse in the presence of symptoms such as chest pain, heart failure, or tachycardia unresponsive to fluid resuscitation

Increasing arterial oxygen content by increasing Hb does not necessarily increase tissue oxygen delivery or uptake Altered rheological properties of transfused cells and increasing Hct increases viscosity Reduce blood flow through the microcirculation.

2016 patients aged > 50 years old who had either a history or risk factors for cardiovascular disease and whose hemoglobin was <10g/dL following surgery for hip fracture

Carsons et al - FOCUS Trial Random assignment to a liberal transfusion strategy or a restrictive transfusion strategy Findings Transfusions were 3x higher in the liberal group Similar rates of primary outcome Similar rates of in-hospital cardiac event or death Similar rates of death at 60 day follow up similar No benefit of using liberal transfusion strategy in elderly patients at high cardiovascular risk

TBI may require liberal transfusion strategies to prevent secondary cerebral ischaemic Injured brain may not compensate for decreased oxygen delivery associated with anaemia RCT using a factorial design compared the effects of erythropoietin and two different haemoglobin thresholds for red blood cell transfusion (7 versus 10 g/dl) in 200 patients with a closed head injury Showed no difference in neurological outcome at six months

Evidence in Cardiac Surgery Johnson et al.(1993) Bracey et al.(1999) Hajjar et al.(2010) RCTs in patients undergoing elective coronary artery bypass, valve replacements or a mixture of both. All three trials used different transfusion thresholds with the lowest being Hct < 25% although this was a small study The TRACS trial showed that a restrictive strategy (Hct < 24%, mean Hb 91 gr/l) appears to be as safe as liberal strategy (Hct < 30%, mean Hb 10.5 gr/l).

Evidence in Vascular Surgery Bush et al.(1997) RCT in patients undergoing elective aortic or infrainguinal arterial reconstruction Liberal group had Hb maintained at 100 gr/l, n = 49 Restrictive group were transfused only if Hb < 90 gr/l, n = 50 There were no significant differences in mortality, cardiac morbidity and hospital LOS between both groups. However, the liberal group had a postoperative Hb 110±12 gr/l and the restrictive group had a postoperative Hb 98±13 gr/l

Evidence in Orthopedic Surgery Carson et al.(1998) Grover et al.(2005) Foss et al.(2009) Carson et al.(2011) Parker(2013) So-Osman et al.(2013) All these RCTs focused on major lower limb surgery elective hip/knee arthroplasty or hip fracture repair. There was heterogeneity between the studies with regard to the transfusion triggers used. The lowest restrictive transfusion trigger was 80 g/l The FOCUS trial showed that a restrictive transfusion strategy (symptoms of anaemia or at physician discretion for an Hb < 80 gr/l) was safe even in patients with history/risk factors for cardiovascular disease. Overall, a restrictive transfusion strategy appears to be safe for majority of patients undergoing orthopaedic lower limb surgery. However in patients presenting with acute cardiac disease or any other organ dysfunction (e.g. heart failure, sepsis), it may be sensible to adopt a less restrictive strategy aiming for an Hb between 90 and 100 gr/l.

Evidence in Plastic Surgery Rossmiller et al.(2010) There was no significant increase in the rate of complications, including flap loss, in the restrictive group. However, there are no RCTs yet in this subgroup of patients

Summary Restricted transfusion strategy is to transfuse patient when hgb < 7 gr/dl and maintain between 7-9 gr/dl Higher limit will not bring better outcome due to altered rheology properties of transfused cells MABL computation is no longer an ideal transfusion trigger, it serves as high alert, triggers should be presence of symptoms

Overwhelming ample evidence supporting restricted transfusion strategy Will YOU still transfuse unnecessarily???